Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
NCT04515810 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2026-05-18
Summary
This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.
Conditions
- Malignant Solid Neoplasm
Interventions
- OTHER
-
Internet-Based Intervention
Use smartphone application
- OTHER
-
Best Practice
Engage in standard care
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Fred Hutchinson Cancer Center
lead OTHER
Principal Investigators
-
Megan J Shen, PhD · Fred Hutch/University of Washington Cancer Consortium
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-18
- Primary Completion
- 2026-08-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy
NCT02193672 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
NCT00565721 ·Status: COMPLETED ·Phase: PHASE2
-
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
NCT02055586 ·Status: COMPLETED
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
NCT03493789 ·Status: COMPLETED ·Phase: PHASE1
-
Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
NCT00147472 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Tracer PET Assessment of Primary Brain Tumors
NCT00813566 ·Status: COMPLETED ·Phase: PHASE1
-
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
NCT01530269 ·Status: COMPLETED ·Phase: PHASE2
-
Positron Emission Tomography in Prostate Cancer
NCT00121212 ·Status: COMPLETED ·Phase: NA
-
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
NCT01712815 ·Status: TERMINATED ·Phase: NA
-
FACBC Prostate Therapy Response
NCT02830880 ·Status: COMPLETED ·Phase: PHASE2
-
[18F]Fluciclatide PET Imaging of Pazopanib Response
NCT01961583 ·Status: TERMINATED ·Phase: PHASE2
-
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
NCT00588185 ·Status: RECRUITING ·Phase: NA
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
NCT06448208 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 ·Status: COMPLETED
-
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00227539 ·Status: COMPLETED ·Phase: PHASE2
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
NCT02485834 ·Status: TERMINATED ·Phase: PHASE2
-
PET Scan in Treating Patients With Metastatic Prostate Cancer
NCT00002981 ·Status: COMPLETED ·Phase: NA
-
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938 ·Status: COMPLETED
-
PET Scans in Patients With Locally Advanced Breast Cancer
NCT00109785 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)
NCT01050283 ·Status: TERMINATED ·Phase: PHASE1
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
NCT00416455 ·Status: COMPLETED ·Phase: PHASE1/PHASE2